Cellular model systems to study the tumor biological role of kallikrein-related peptidases in ovarian and prostate cancer

Novel cancer-related biomarkers

Volumn , Issue , 2012, Pages 83-110

  Dong, Ying ^a   Loessner, Daniela ^a   Sieh, Shirly ^a   Taubenberger, Anna ^a   Fuhrman Luck, Ruth A ^a   Magdolen, Viktor ^b   Hutmacher, Dietmar W ^a   Clements, Judith A ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84894972938     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (123)

1. Abbott, A. (2003). Cell culture: biology's new dimension. Nature 424, 870-872
2. Agre, P., and Williams, T.E. (1983). The human tumor cloning assay in cancer drug development. A review. Invest. New Drugs 1, 33-45
3. AIHW (2010). Ovarian cancer in Australia: an overview. In Cancer Series Number 52 (Canberra, Australia, Australian Institute of Health and Welfare)
4. Alberts, D.S., Samon, S.E., Chen, H.S., Surwit, E.A., Soehnlen, B., Young, L., and Moon, T.E. (1980). In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet 2, 340-342
5. Auerbach, R., Lewis, R., Shinners, B., Kubai, L., and Akhtar, N. (2003). Angiogenesis assays: a critical overview. Clin. Chem. 49, 32-40
6. Barbolina, M.V., Adley, B.P., Ariztia, E.V., Liu, Y., and Stack, M.S. (2007). Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression. J. Biol. Chem. 282, 4924-4931
7. Barbolina, M.V., Adley, B.P., Kelly, D.L., Shepard, J., Fought, A.J., Scholtens, D., Penzes, P., Shea, L.D., and Stack, M.S. (2009a). Downregulation of connective tissue growth factor by threedimensional matrix enhances ovarian carcinoma cell invasion. Int. J. Cancer 125, 816-825
8. Barbolina, M.V., Moss, N.M., Westfall, S.D., Lui, Y., Burkhalter, R.J., Marga, F., Forgacs, G., Hudson, L.G., and Stack, M.S. (2009b). Microenvironmental regulation of ovarian cancer metastasis. In: Ovarian Cancer, Stack, M.S., and Fishman, D.A., eds. (New York, Springer), pp. 319-334
9. Barrett, J.M., Mangold, K.A., Jilling, T., and Kaul, K.L. (2005). Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture. Prostate 64, 75-82
10. Bast, R.C. Jr., Hennessy, B., and Mills, G.B. (2009). The biology of ovarian cancer: new opportunities for translation. Nat. Rev. Cancer 9, 415-428
11. Berrino, F., De Angelis, R., Sant, M., Rosso, S., Bielska-Lasota, M., Coebergh, J.W., and Santaquilani, M. (2007). Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol. 8, 773-783
12. Bertelsen, C.A., Sondak, V.K., Mann, B.D., Korn, E.L., and Kern, D.H. (1984). Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations. Cancer 53, 1240-1245
13. Bissell, D.M., Arenson, D.M., Maher, J.J., and Roll, F.J. (1987). Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver. J. Clin. Invest. 79, 801-812
14. Bissell, M.J., and Barcellos-Hoff, M.H. (1987). The influence of extracellular matrix on gene expression: is structure the message? J. Cell Sci. Suppl. 8, 327-343
15. Bissell, M.J., Hall, H.G., and Parry, G. (1982). How does the extracellular matrix direct gene expression? J. Theor. Biol. 99, 31-68
16. Bissell, M.J., and Radisky, D. (2001). Putting tumours in context. Nat. Rev. Cancer 1, 46-54
17. Borgoño, C.A., and Diamandis, E.P. (2004). The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer 4, 876-890
18. Burleson, K.M., Casey, R.C., Skubitz, K.M., Pambuccian, S.E., Oegema, T.R. Jr., and Skubitz, A.P. (2004a). Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol. Oncol. 93, 170-181
19. Burleson, K.M., Hansen, L.K., and Skubitz, A.P. (2004b). Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers. Clin. Exp. Metastasis 21, 685-697
20. Cancer-Research-UK. (2011). Ovarian cancer survival statistics
21. Cannistra, S.A. (2004). Cancer of the ovary. N. Engl. J. Med. 351, 2519-2529
22. Casey, R.C., Burleson, K.M., Skubitz, K.M., Pambuccian, S.E., Oegema, T.R. Jr., Ruff, L.E., and Skubitz, A.P. (2001). ß1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am. J. Pathol. 159, 2071-2080
23. Chadha, K.C., Nair, B.B., Chakravarthi, S., Zhou, R., Godoy, A., Mohler, J.L., Aalinkeel, R., Schwartz, S.A., and Smith, G.J. (2011). Enzymatic activity of free-prostate-specific antigen (f-PSA) is not required for some of its physiological activities. Prostate 71, 1680-1690
24. Chu, Y.W., Runyan, R.B., Oshima, R.G., and Hendrix, M.J. (1993). Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc. Natl. Acad. Sci. USA 90, 4261-4265
25. Clements, J.A., Willemsen, N.M., Myers, M., and Dong, Y. (2004). The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 41, 265-312
26. Cukierman, E., Pankov, R., and Yamada, K.M. (2002). Cell interactions with three-dimensional matrices. Curr. Opin. Cell Biol. 14, 633-639
27. Davies, E.J., Blackhall, F.H., Shanks, J.H., David, G., McGown, A.T., Swindell, R., Slade, R.J., Martin-Hirsch, P., Gallagher, J.T., and Jayson, G.C. (2004). Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. Clin. Cancer Res. 10, 5178-5186
28. Doillon, C.J., Gagnon, E., Paradis, R., and Koutsilieris, M. (2004). Three-dimensional culture system as a model for studying cancer cell invasion capacity and anticancer drug sensitivity. Anticancer Res. 24, 2169-2177
29. Dong, Y., Tan, O.L., Loessner, D., Stephens, C., Walpole, C., Boyle, G.M., Parsons, P.G., and Clements, J.A. (2010). Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res. 70, 2624-2633
30. Durand, R.E., and Olive, P.L. (2001). Resistance of tumor cells to chemo-and radiotherapy modulated by the three-dimensional architecture of solid tumors and spheroids. Methods Cell Biol. 64, 211-233
31. Essand, M., Gronvik, C., Hartman, T., and Carlsson, J. (1995). Radioimmunotherapy of prostatic adenocarcinomas: effects of 131I-labelled E4 antibodies on cells at different depth in DU 145 spheroids. Int. J. Cancer 63, 387-394
32. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., and Mooney, D.J. (2007). Engineering tumors with 3D scaffolds. Nat. Methods 4, 855-860
33. Fortier, A.H., Nelson, B.J., Grella, D.K., and Holaday, J.W. (1999). Antiangiogenic activity of prostatespecific antigen. J. Natl. Cancer Inst. 91, 1635-1640
34. Frankel, A., Buckman, R., and Kerbel, R.S. (1997). Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res. 57, 2388-2393
35. Frankel, A., Man, S., Elliott, P., Adams, J., and Kerbel, R.S. (2000). Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin. Cancer Res. 6, 3719-3728
36. Friedrich, J., Ebner, R., and Kunz-Schughart, L.A. (2007). Experimental anti-tumor therapy in 3-D: spheroids-old hat or new challenge? Int. J. Radiat. Biol. 83, 849-871
37. Friedrich, J., Seidel, C., Ebner, R., and Kunz-Schughart, L.A. (2009). Spheroid-based drug screen: considerations and practical approach. Nat. Protoc. 4, 309-324
38. Gao, J., Collard, R.L., Bui, L., Herington, A.C., Nicol, D.L., and Clements, J.A. (2007). Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer. Prostate 67, 348-360
39. Ghajar, C.M., and Bissell, M.J. (2010). Tumor engineering: the other face of tissue engineering. Tissue Eng. Part A 16, 2153-2156
40. Ghajar, C.M., Kachgal, S., Kniazeva, E., Mori, H., Costes, S.V., George, S.C., and Putnam, A.J. (2010). Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp. Cell Res. 316, 813-825
41. Giusti, B., Serrati, S., Margheri, F., Papucci, L., Rossi, L., Poggi, F., Magi, A., Del Rosso, A., Cinelli, M., Guiducci, S., Kahaleh, B., Matucci-Cerinic, M., Abbate, R., Fibbi, G., and Del Rosso, M. (2005). The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. Arthritis Rheum. 52, 3618-3628
42. Goodman, M.T., Correa, C.N., Tung, K.H., Roffers, S.D., Cheng Wu, X., Young, J.L. Jr., Wilkens, L.R., Carney, M.E., and Howe, H.L. (2003). Stage at diagnosis of ovarian cancer in the United States, 1992-1997. Cancer 97, 2648-2659
43. Griffith, L.G., and Swartz, M.A. (2006). Capturing complex 3D tissue physiology in vitro. Nat. Rev. Mol. Cell. Biol. 7, 211-224
44. Hamburger, A.W. (1987). The human tumor clonogenic assay as a model system in cell biology. Int. J. Cell Cloning 5, 89-107
45. Harma, V., Virtanen, J., Makela, R., Happonen, A., Mpindi, J.P., Knuuttila, M., Kohonen, P., Lotjonen, J., Kallioniemi, O., and Nees, M. (2010). A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses. PLoS One 5, e10431
46. Hedlund, T.E., Duke, R.C., and Miller, G.J. (1999). Three-dimensional spheroid cultures of human prostate cancer cell lines. Prostate 41, 154-165
47. Hedman, K., Johansson, S., Vartio, T., Kjellen, L., Vaheri, A., and Hook, M. (1982). Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectinprocollagen fibers. Cell 28, 663-671
48. Helenius, J., Heisenberg, C.P., Gaub, H.E., and Muller, D.J. (2008). Single-cell force spectroscopy. J. Cell Sci. 121, 1785-1791
49. Hsiao, A.Y., Torisawa, Y.S., Tung, Y.C., Sud, S., Taichman, R.S., Pienta, K.J., and Takayama, S. (2009). Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids. Biomaterials 30, 3020-3027
50. Hutmacher, D.W., Horch, R.E., Loessner, D., Rizzi, S., Sieh, S., Reichert, J.C., Clements, J.A., Beier, J.P., Arkudas, A., Bleiziffer, O., and Kneser, U. (2009). Translating tissue engineering technology platforms into cancer research. J. Cell. Mol. Med. 13, 1417-1427
51. Hutmacher, D.W. (2010). Biomaterials offer cancer research the third dimension. Nat. Mater. 9, 90-93
52. Ingram, M., Techy, G.B., Saroufeem, R., Yazan, O., Narayan, K.S., Goodwin, T.J., and Spaulding, G.F. (1997). Three-dimensional growth patterns of various human tumor cell lines in simulated microgravity of a NASA bioreactor. In Vitro Cell Dev. Biol. Anim. 33, 459-466
53. Iwanicki, M.P., Davidowitz, R.A., Ng, M.R., Besser, A., Muranen, T., Merritt, M., Danuser, G., Ince, T., and Brugge, J.S. (2011). Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discovery 1, 144-157
54. Jedeszko, C., Sameni, M., Olive, M.B., Moin, K., and Sloane, B.F. (2008). Visualizing protease activity in living cells: from two dimensions to four dimensions. Curr. Protoc. Cell Biol., Chapter 4, Unit 4, 20
55. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J. Clin. 61, 69-90
56. Josson, S., Matsuoka, Y., Chung, L.W., Zhau, H.E., and Wang, R. (2010). Tumor-stroma co-evolution in prostate cancer progression and metastasis. Semin. Cell. Dev. Biol. 21, 26-32
57. Kaminski, A., Hahne, J.C., Haddouti el, M., Florin, A., Wellmann, A., and Wernert, N. (2006). Tumourstroma interactions between metastatic prostate cancer cells and fibroblasts. Int. J. Mol. Med. 18, 941-950
58. Kaneko, A., Satoh, Y., Tokuda, Y., Fujiyama, C., Udo, K., and Uozumi, J. (2010). Effects of adipocytes on the proliferation and differentiation of prostate cancer cells in a 3-D culture model. Int. J. Urol. 17, 369-376
59. Kenny, H.A., Kaur, S., Coussens, L.M., and Lengyel, E. (2008). The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest. 118, 1367-1379
60. Kenny, H.A., Krausz, T., Yamada, S.D., and Lengyel, E. (2007). Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum. Int. J. Cancer 121, 1463-1472
61. Kenny, H.A., and Lengyel, E. (2009). MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle 8, 683-688
62. Kim, J.B. (2005). Three-dimensional tissue culture models in cancer biology. Semin. Cancer Biol. 15, 365-377
63. Kleinman, H.K., McGarvey, M.L., Hassell, J.R., Star, V.L., Cannon, F.B., Laurie, G.W., and Martin, G.R. (1986). Basement membrane complexes with biological activity. Biochemistry 25, 312-318
64. Klokk, T.I., Kilander, A., Xi, Z., Waehre, H., Risberg, B., Danielsen, H.E., and Saatcioglu, F. (2007). Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. Cancer Res. 67, 5221-5230
65. Lawrence, M.G., Lai, J., and Clements, J.A. (2010). Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. Endocr. Rev. 31, 407-446
66. Li, S.H., Hawthorne, V.S., Neal, C.L., Sanghera, S., Xu, J., Yang, J., Guo, H., Steeg, P.S., and Yu, D. (2009). Upregulation of neutrophil gelatinase-associated lipocalin by ErbB2 through nuclear factor-kappaB activation. Cancer Res. 69, 9163-9168
67. Lilja, H., Ulmert, D., and Vickers, A.J. (2008). Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat. Rev. Cancer 8, 268-278
68. Lim, R., Ahmed, N., Borregaard, N., Riley, C., Wafai, R., Thompson, E.W., Quinn, M.A., and Rice, G.E. (2007). Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epitheliomesenchymal transition. Int. J. Cancer 120, 2426-2434
69. Lin, C.C., and Anseth, K.S. (2009). PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm. Res. 26, 631-643
70. Liotta, L.A., Tryggvason, K., Garbisa, S., Hart, I., Foltz, C.M., and Shafie, S. (1980). Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284, 67-68
71. Loessner, D., Stok, K.S., Lutolf, M.P., Hutmacher, D.W., Clements, J.A., and Rizzi, S.C. (2010). Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31, 8494-8506
72. Madar, S., Brosh, R., Buganim, Y., Ezra, O., Goldstein, I., Solomon, H., Kogan, I., Goldfinger, N., Klocker, H., and Rotter, V. (2009). Modulated expression of WFDC1 during carcinogenesis and cellular senescence. Carcinogenesis 30, 20-27
73. Mo, L., Zhang, J., Shi, J., Xuan, Q., Yang, X., Qin, M., Lee, C., Klocker, H., Li, Q.Q., and Mo, Z. (2010). Human kallikrein 7 induces epithelial-mesenchymal transition-like changes in prostate carcinoma cells: a role in prostate cancer invasion and progression. Anticancer Res. 30, 3413-3420
74. Moss, N.M., Barbolina, M.V., Liu, Y., Sun, L., Munshi, H.G., and Stack, M.S. (2009a). Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in I.p. metastatic dissemination. Cancer Res. 69, 7121-7129
75. Moss, N.M., Liu, Y., Johnson, J.J., Debiase, P., Jones, J., Hudson, L.G., Munshi, H.G., and Stack, M.S. (2009b). Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen. Mol. Cancer Res. 7, 809-820
76. Mucci, L.A., Powolny, A., Giovannucci, E., Liao, Z., Kenfield, S.A., Shen, R., Stampfer, M.J., and Clinton, S.K. (2009). Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study. J. Clin. Oncol. 27, 5627-5633
77. Nelson, C.M., and Bissell, M.J. (2006). Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu. Rev. Cell. Dev. Biol. 22, 287-309
78. Paland, N., Kamer, I., Kogan-Sakin, I., Madar, S., Goldfinger, N., and Rotter, V. (2009). Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer. Mol. Cancer Res. 7, 1212-1223
79. Pampaloni, F., Reynaud, E.G., and Stelzer, E.H. (2007). The third dimension bridges the gap between cell culture and live tissue. Nat. Rev. Mol. Cell. Biol. 8, 839-845
80. Petersen, O.W., Ronnov-Jessen, L., Howlett, A.R., and Bissell, M.J. (1992). Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc. Natl. Acad. Sci. USA 89, 9064-9068
81. Pickl, M., and Ries, C.H. (2009). Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 28, 461-468
82. Podgorski, I., Linebaugh, B.E., Sameni, M., Jedeszko, C., Bhagat, S., Cher, M.L., and Sloane, B.F. (2005). Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer. Neoplasia 7, 207-223
83. Prestwich, G.D. (2007). Simplifying the extracellular matrix for 3-D cell culture and tissue engineering: a pragmatic approach. J. Cell. Biochem. 101, 1370-1383
84. Prezas, P., Arlt, M.J., Viktorov, P., Soosaipillai, A., Holzscheiter, L., Schmitt, M., Talieri, M., Diamandis, E.P., Krüger, A., and Magdolen, V. (2006). Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol. Chem. 387, 807-811
85. Puech, P.H., Poole, K., Knebel, D., and Muller, D.J. (2006). A new technical approach to quantify cell-cell adhesion forces by AFM. Ultramicroscopy 106, 637-644
86. Puls, L.E., Duniho, T., Hunter, J.E., Kryscio, R., Blackhurst, D., and Gallion, H. (1996). The prognostic implication of ascites in advanced-stage ovarian cancer. Gynecol. Oncol. 61, 109-112
87. Reichert, J.C., Quent, V.M., Burke, L.J., Stansfield, S.H., Clements, J.A., and Hutmacher, D.W. (2010). Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment. Biomaterials 31, 7928-7936
88. Rizzi, S.C., and Hubbell, J.A. (2005). Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part I: Development and physicochemical characteristics. Biomacromolecules 6, 1226-1238
89. Rizzi, S.C., Ehrbar, M., Halstenberg, S., Raeber, G.P., Schmoekel, H.G., Hagenmuller, H., Muller, R., Weber, F.E., and Hubbell, J.A. (2006). Recombinant protein-co-PEG networks as cell-adhesive and proteolytically degradable hydrogel matrixes. Part II: biofunctional characteristics. Biomacromolecules 7, 3019-3029
90. Robb, J.A. (1970). Microcloning and replica plating of mammalian cells. Science 170, 857-858
91. Rodan, S.B., Imai, Y., Thiede, M.A., Wesolowski, G., Thompson, D., Bar-Shavit, Z., Shull, S., Mann, K., and Rodan, G.A. (1987). Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties. Cancer Res. 47, 4961-4966
92. Sameni, M., Dosescu, J., Yamada, K.M., Sloane, B.F., and Cavallo-Medved, D. (2008). Functional live-cell imaging demonstrates that beta1-integrin promotes type IV collagen degradation by breast and prostate cancer cells. Mol. Imaging 7, 199-213
93. Schmidt, J.J., Rowley, J., and Kong, H.J. (2008). Hydrogels used for cell-based drug delivery. J. Biomed. Mater. Res. A 87, 1113-1122
94. Schneider, J.G., Amend, S.R., and Weilbaecher, K.N. (2011). Integrins and bone metastasis: integrating tumor cell and stromal cell interactions. Bone 48, 54-65
95. Schubert, D., and LaCorbiere, M. (1982). Properties of extracellular adhesion-mediating particles in myoblast clone and its adhesion-deficient variant. J. Cell. Biol. 94, 108-114
96. Schuetz, E.G., Li, D., Omiecinski, C.J., Muller-Eberhard, U., Kleinman, H.K., Elswick, B., and Guzelian, P.S. (1988). Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J. Cell. Physiol. 134, 309-323
97. Schutyser, E., Struyf, S., Proost, P., Opdenakker, G., Laureys, G., Verhasselt, B., Peperstraete, L., Van de Putte, I., Saccani, A., Allavena, P., Mantovani, A., and van Damme, J. (2002). Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J. Biol. Chem. 277, 24584-24593
98. Shield, K., Riley, C., Quinn, M.A., Rice, G.E., Ackland, M.L., and Ahmed, N. (2007). Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J. Carcinog. 6, 11
99. Shou, J., Soriano, R., Hayward, S.W., Cunha, G.R., Williams, P.M., and Gao, W.Q. (2002). Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc. Natl. Acad. Sci. USA 99, 2830-2835
100. Sodek, K.L., Brown, T.J., and Ringuette, M.J. (2008). Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration. BMC Cancer 8, 223
101. Sodek, K.L., Ringuette, M.J., and Brown, T.J. (2009). Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int. J. Cancer 124, 2060-2070
102. Sotiropoulou, G., Pampalakis, G., and Diamandis, E.P. (2009). Functional roles of human kallikreinrelated peptidases. J. Biol. Chem. 284, 32989-32994
103. Stewart, J.J., White, J.T., Yan, X., Collins, S., Drescher, C.W., Urban, N.D., Hood, L., and Lin, B. (2006). Proteins associated with cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol. Cell. Proteomics 5, 433-443
104. Sung, S.Y., Hsieh, C.L., Law, A., Zhau, H.E., Pathak, S., Multani, A.S., Lim, S., Coleman, I.M., Wu, L.C., Figg, W.D., Dahut, W.L., Nelson, P., Lee, J.K., Amin, M.B., Lyles, R., Johnstone, P.A., Marshall, F.F., and Chung, L.W. (2008). Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis. Cancer Res. 68, 9996-10003
105. Sutherland, R.M., MacDonald, H.R., and Howell, R.L. (1977). Multicellular spheroids: a new model target for in vitro studies of immunity to solid tumor allografts. J. Natl. Cancer Inst. 58, 1849-1853
106. Sweeney, T.M., Kibbey, M.C., Zain, M., Fridman, R., and Kleinman, H.K. (1991). Basement membrane and the SIKVAV laminin-derived peptide promote tumor growth and metastases. Cancer Metastasis Rev. 10, 245-254
107. Taubenberger, A., Cisneros, D.A., Friedrichs, J., Puech, P.H., Muller, D.J., and Franz, C.M. (2007). Revealing early steps of alpha2beta1 integrin-mediated adhesion to collagen type I by using single-cell force spectroscopy. Mol. Biol. Cell 18, 1634-1644
108. Thanos, C.G., and Emerich, D.F. (2008). On the use of hydrogels in cell encapsulation and tissue engineering system. Recent Pat. Drug Deliv. Formul. 2, 19-24
109. Tuxhorn, J.A., McAlhany, S.J., Dang, T.D., Ayala, G.E., and Rowley, D.R. (2002). Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Cancer Res. 62, 3298-3307
110. Vamvakidou, A.P., Mondrinos, M.J., Petushi, S.P., Garcia, F.U., Lelkes, P.I., and Tozeren, A. (2007). Heterogeneous breast tumoroids: An in vitro assay for investigating cellular heterogeneity and drug delivery. J. Biomol. Screen. 12, 13-20
111. Vanpoucke, G., Orr, B., Grace, O.C., Chan, R., Ashley, G.R., Williams, K., Franco, O.E., Hayward, S.W., and Thomson, A.A. (2007). Transcriptional profiling of inductive mesenchyme to identify molecules involved in prostate development and disease. Genome Biol. 8, R213
112. Veveris-Lowe, T.L., Lawrence, M.G., Collard, R.L., Bui, L., Herington, A.C., Nicol, D.L., and Clements, J.A. (2005). Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr. Relat. Cancer 12, 631-643
113. Walsh, P.C., DeWeese, T.L., and Eisenberger, M.A. (2007). Clinical practice. Localized prostate cancer. N. Engl. J. Med. 357, 2696-2705
114. Wang, J., Ying, G., Jung, Y., Lu, J., Zhu, J., Pienta, K.J., and Taichman, R.S. (2010). Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression. Cancer Res. 70, 471-480
115. Witz, C.A., Montoya-Rodriguez, I.A., Cho, S., Centonze, V.E., Bonewald, L.F., and Schenken, R.S. (2001). Composition of the extracellular matrix of the peritoneum. J. Soc. Gynecol. Investig. 8, 299-304
116. Wong, C.P., Bray, T.M., and Ho, E. (2009). Induction of proinflammatory response in prostate cancer epithelial cells by activated macrophages. Cancer Lett. 276, 38-46
117. Xi, Z., Kaern, J., Davidson, B., Klokk, T.I., Risberg, B., Trope, C., and Saatcioglu, F. (2004). Kallikrein 4 is associated with paclitaxel resistance in ovarian cancer. Gynecol. Oncol. 94, 80-85
118. Yamada, K.M., and Cukierman, E. (2007). Modeling tissue morphogenesis and cancer in 3D. Cell 130, 601-610
119. Yamamura, K., Kibbey, M.C., Jun, S.H., and Kleinman, H.K. (1993). Effect of matrigel and laminin peptide YIGSR on tumor growth and metastasis. Semin. Cancer Biol. 4, 259-265
120. Yousef, G.M., and Diamandis, E.P. (2009). The human kallikrein gene family: new biomarkers for ovarian cancer. In: Ovarian Cancer, Stack, M.S., and Fishman, D.A., eds. (New York, Springer), pp. 165-188
121. Zhang, X., Wojcikiewicz, E., and Moy, V.T. (2002). Force spectroscopy of the leukocyte functionassociated antigen-1/intercellular adhesion molecule-1 interaction. Biophys. J. 83, 2270-2279
122. Zhao, H., and Peehl, D.M. (2009). Tumor-promoting phenotype of CD90hi prostate cancer-associated fibroblasts. Prostate 69, 991-1000
123. Zhau, H.E., Goodwin, T.J., Chang, S.M., Baker, T.L., and Chung, L.W. (1997). Establishment of a threedimensional human prostate organoid coculture under microgravity-simulated conditions: evaluation of androgen-induced growth and PSA expression. In Vitro Cell. Dev. Biol. Anim. 33, 375-380